4.6 Article

The role of wide local excision for the treatment of severe hidradenitis suppurativa (Hurley grade III): Retrospective analysis of 74 patients

期刊

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2017.01.055

关键词

acne inversa; DLQI; inflammation; recurrence; satisfaction; surgery; TNF

向作者/读者索取更多资源

Background: Effective medical treatment for patients with severe hidradenitis suppurativa (HS) is limited. Objectives: We sought to measure the impact of wide local excision on quality of life in HS Hurley grade III patients and to examine the rate of postoperative complications, disease recurrences, and satisfaction with the cosmetic results. Methods: Seventy-four patients were enrolled. Outcome measures included Dermatology Life Quality Index responses, disease duration, recurrence, previous therapies, postoperative complications, and satisfaction with cosmetic results. Results: Most patients had inguinogenital/gluteal disease (68.9%, P < .001). Involvement of both the axillary and the inguinogenital/ gluteal areas were pronounced in male patients (P =.018). None of the patients was treated with tumor necrosis factor-a inhibitors. Most patients (71.6%) had a disease history of >5 years at the time of presentation and multiple unsuccessful attempts with systemic and local therapeutic interventions. Wide local excision improved Dermatology Life Quality Index scores from initially 27.89 to 5.31 after surgery (P < .001), independent of localization (P =.195). Forty-seven percent of patients had postoperative complications, most frequently pain and scarring. The vast majority of patients (70.3%) were satisfied with the cosmetic results. Limitations: The retrospective nature of the study was a limitation. Conclusions: Wide local excision significantly improves the quality of life of HS patients. Local recurrence rates are low, and satisfaction with the cosmetic results is high.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Dermatology

Bullous Sweet's syndrome with pulmonary involvement

A. Sesti, K. Rappersberger, C. Posch

HAUTARZT (2017)

Letter Dermatology

Adverse effects of subcutaneous, drug-releasing implants for the treatment of opioid drug addiction

Bal Christina, Rappersberger Klemens, Posch Christian

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2017)

Article Dermatology

Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria

Leo Richter, Igor Vujic, Alma Sesti, Babak Monshi, Martina Sanlorenzo, Christian Posch, Klemens Rappersberger

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2017)

Article Dermatology

Apremilast in psoriasis - a prospective real-world study

I. Vujic, R. Herman, M. Sanlorenzo, C. Posch, B. Monshi, K. Rappersberger, L. Richter

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)

Article Dermatology

Knowledge and Influence of Predatory Journals in Dermatology: A Pan-Austrian Survey

Georg Richtig, Markus Richtig, Wolfram Hoetzenecker, Werner Saxinger, Bernhard Lange-Asschenfeldt, Andreas Steiner, Robert Strohal, Christian Posch, Johann W. Bauer, Robert R. Muellegger, Teresa Deinlein, Norbert Sepp, Beatrix Volc-Platzer, Van Anh Nguyen, Matthias Schmuth, Christoph Hoeller, Gudrun Pregartner, Erika Richtig

ACTA DERMATO-VENEREOLOGICA (2019)

Article Multidisciplinary Sciences

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma

Martina Sanlorenzo, Igor Vujic, Rosaura Esteve-Puig, Kevin Lai, Marin Vujic, Kevin Lin, Christian Posch, Michelle Dimon, Adrian Moy, Mitchell Zekhtser, Katia Johnston, Deborah Gho, Wilson Ho, Abhinay Gajjala, Juan Oses Prieto, Alma Burlingame, Adil Daud, Klemens Rappersberger, Susana Ortiz-Urda

SCIENTIFIC REPORTS (2018)

Letter Oncology

A dual pathway inhibition strategy using BKM120 combined with vemurafenib is poorly tolerated in BRAF V600E/K mutant advanced melanoma

Alain Patrick Algazi, Julia Rotow, Christian Posch, Susana Ortiz-Urda, Alain Patrick Algazi, Pamela N. Munster, Adil Daud

PIGMENT CELL & MELANOMA RESEARCH (2019)

Letter Dermatology

COVID-19 in a melanoma patient under treatment with checkpoint inhibition

P. Schmidle, T. Biedermann, C. Posch

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Editorial Material Dermatology

A fresh perspective on an established marker: S100B-dynamics for early detection of melanoma recurrence

C. Posch

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Letter Oncology

Exceptional response to anti-PD-1 treatment in a patient with metastatic cutaneous hidradenocarcinoma

H. Obermann, P. Schmidle, S. A. Steimle-Grauer, N. Pfarr, C. Posch

EUROPEAN JOURNAL OF CANCER (2021)

Letter Dermatology

Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19

M. Arenbergerova, A. Lallas, E. Nagore, L. Rudnicka, A. M. Forsea, M. Pasek, F. Meier, K. Peris, J. Olah, C. Posch

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Editorial Material Dermatology

Ageing research: rethinking primary prevention of skin cancer COMMENT

C. Posch

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Letter Dermatology

Hyperprogression of Merkel cell carcinoma after avelumab treatment

R. Pirker, A. Fink, A. Stella, L. Stifter, C. Posch

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Medicine, General & Internal

Clinical melanoma characteristics and survival-a single-center retrospective study between 2000 and 2010

Valentin Feichtenschlager, Felix Weihsengruber, Leo Richter, Igor vujic, Klemens Rappersberger, Christian Posch

WIENER MEDIZINISCHE WOCHENSCHRIFT (2019)

暂无数据